Daousani C, Macheras P. Scientific considerations concerning the EMA change in the definition of ``dose{''} of the BCS-based biowaiver guideline and implications for bioequivalence. INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2015;478:606-609.